The price of Linzess (linaclotide) can vary depending on factors such as insurance coverage, pharmacy, and dosage. However, without insurance, a 30-day supply of Linzess can cost several hundred dollars. For example, a 30-day prescription for 145 mcg can range from approximately $500 to over $600 [1]. A 290 mcg dose for the same duration can be similarly priced, potentially exceeding $600 [1].
How much does a prescription for Linzess cost?
The retail price for a 30-day supply of Linzess is generally high. For a 145 mcg dosage, the cost can be around $500 to $600. The 290 mcg dosage for a 30-day supply also falls in a similar price range, sometimes exceeding $600. These figures represent the cost without insurance [1].
What is the cost of Linzess with insurance?
With insurance, the out-of-pocket cost for Linzess can be significantly lower. Many insurance plans offer copay assistance programs or have lower copayments for preferred medications. The exact cost will depend on the specific insurance plan's formulary, deductible, and copay structure [1].
Are there any patient assistance programs for Linzess?
Yes, there are patient assistance programs available for Linzess. The manufacturer, Ironwood Pharmaceuticals, offers a savings card that can reduce the copay for eligible commercially insured patients. This program can bring the monthly cost down to as low as $30 [1]. Patients who are uninsured or underinsured may also be eligible for other assistance programs.
What is the price difference between Linzess dosages?
While the price can fluctuate, dosages of Linzess like 145 mcg and 290 mcg for a 30-day supply often fall within a similar price bracket, generally ranging from $500 to over $600 without insurance. The price is more consistently tied to the quantity and duration of the prescription rather than minor variations in dosage strength for the same supply period [1].
How does the price of Linzess compare to other IBS-C medications?
Linzess is a prescription medication used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Comparing its price to other medications in this category, such as Amitiza (lubiprostone) or Trulance (plecanatide), reveals that these drugs also represent a significant cost for patients, particularly without insurance. The specific price points and insurance coverage for these alternatives can differ, impacting the overall cost comparison for an individual patient [1].
When does the Linzess patent expire?
Information on patent expiry for Linzess is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents. Understanding patent timelines is crucial for predicting when generic versions might become available and potentially lower the medication's cost [2]. For specific details on Linzess's patent status, consulting such specialized databases is recommended.
Are there generic alternatives for Linzess?
As of now, there are no generic alternatives for Linzess. The availability of generic versions typically follows the expiration of the drug's patents. Until generic Linzess becomes available, the brand-name medication remains the primary treatment option, contributing to its current pricing structure [2].
Sources:
1. https://www.drugpatentwatch.com/drug/linzess
2. https://www.drugpatentwatch.com/